SCHEMBL30188282

SCHEMBL30188282

CN(C(=O)c1ccc2cccn2c1)[C@@H]1CNCc2[nH]c(=O)c3cc(F)c(F)cc3c21

nearest known ligand 0.38

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29301543 1.00 CYP2D6 (0.38) CYP2D6
SCHEMBL30188459 1.00 CYP2D6 (0.38) CYP2D6
SCHEMBL30188469 1.00 CYP2D6 (0.38) CYP2D6
SCHEMBL29301375 0.91 CYP2D6 (0.38) CYP2D6
SCHEMBL30188318 0.91 CYP2D6 (0.38) CYP2D6
SCHEMBL30188421 0.91 CYP2D6 (0.38) CYP2D6
SCHEMBL28926062 0.89 CYP2D6 (0.38) CYP2D6
SCHEMBL30188387 0.89 CYP2D6 (0.38) CYP2D6
SCHEMBL30188290 0.89 CYP2D6 (0.39) CYP2D6
SCHEMBL30188550 0.89 CYP2D6 (0.39) CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4149945-A1 SUBSTITUTED TRICYCLIC AMIDES, ANALOGUES THEREOF, AND METHODS USING SAME Arbutus Biopharma Corporation (CA) 2023-03-22 EP claimed
EP-4149945-A1 SUBSTITUTED TRICYCLIC AMIDES, ANALOGUES THEREOF, AND METHODS USING SAME Arbutus Biopharma Corporation (CA) 2023-03-22 EP disclosed